Renal function in β-thalassemia major patients treated with two different iron-chelation regimes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Renal function in β-thalassemia major patients treated with two different iron-chelation regimes ; volume:22 ; number:1 ; day:20 ; month:12 ; year:2021 ; pages:1-11 ; date:12.2021
BMC nephrology ; 22, Heft 1 (20.12.2021), 1-11, 12.2021
- Creator
-
Tanous, Osama
Azulay, Yossi
Halevy, Raphael
Dujovny, Tal
Swartz, Neta
Colodner, Raul
Koren, Ariel
Levin, Carina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-021-02630-5
- URN
-
urn:nbn:de:101:1-2022041421385190695096
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tanous, Osama
- Azulay, Yossi
- Halevy, Raphael
- Dujovny, Tal
- Swartz, Neta
- Colodner, Raul
- Koren, Ariel
- Levin, Carina
- SpringerLink (Online service)
Other Objects (12)
Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure
Iron overload and chelation in thalassaemia : a symposium held during the 2nd International Conference on Thalassemia and the Hemoglobinopathies, Herakleion, Crete, 1987
Intracellular iron chelation modulates the macrophage iron phenotype with consequences on tumor progression
Growth and endocrinopathies among children with β-Thalassemia major treated at Dubai Thalassemia centre
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction
Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program
The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation
Role of iron chelation in hemorrhagic myocardial infarction: a quantitative CMR study
The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation
The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation
HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy
Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure
Iron overload and chelation in thalassaemia : a symposium held during the 2nd International Conference on Thalassemia and the Hemoglobinopathies, Herakleion, Crete, 1987
Intracellular iron chelation modulates the macrophage iron phenotype with consequences on tumor progression
Growth and endocrinopathies among children with β-Thalassemia major treated at Dubai Thalassemia centre
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction
Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program
The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation
Role of iron chelation in hemorrhagic myocardial infarction: a quantitative CMR study
The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation
The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation
HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy
Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure
Iron overload and chelation in thalassaemia : a symposium held during the 2nd International Conference on Thalassemia and the Hemoglobinopathies, Herakleion, Crete, 1987
Intracellular iron chelation modulates the macrophage iron phenotype with consequences on tumor progression
Growth and endocrinopathies among children with β-Thalassemia major treated at Dubai Thalassemia centre
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction
Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program
The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation
Role of iron chelation in hemorrhagic myocardial infarction: a quantitative CMR study
The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation
The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation